A phase II trial of lenvatinib plus toripalimab and hepatic arterial infusion chemotherapy as a first-line treatment for advanced hepatocellular carcinoma (LTHAIC study).

被引：20
|
作者：
He, MinKe [1 ]
Ming, Shi [1 ]
Lai, Zhicheng [1 ]
Li, QiJiong [1 ]
机构：
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Hepatobiliary Oncol,Canc Ctr, Guangzhou, VA, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.4083
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4083
引用
收藏
页数：4
相关论文
共 50 条
  • [41] PHASE 3 STUDY OF PEMBROLIZUMAB plus BELZUTIFAN plus LENVATINIB OR PEMBROLIZUMAB/QUAVONLIMAB plus LENVATINIB VERSUS PEMBROLIZUMAB plus LENVATINIB AS FIRST-LINE TREATMENT FOR ADVANCED RENAL CELL CARCINOMA
    Choueiri, Toni
    Plimack, Elizabeth
    Powles, Thomas
    Voss, Martin
    Gurney, Howard
    Silverman, Rachel
    Perini, Rodolfo
    Rodriguez-Lopez, Karla
    Rini, Brian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A447 - A447
  • [42] Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma
    Mei, Jie
    Tang, Yu-Hao
    Wei, Wei
    Shi, Ming
    Zheng, Lie
    Li, Shao-Hua
    Guo, Rong-Ping
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial (vol 27, pg 1536, 2021)
    Mai, Hai-Qiang
    Chen, Qiu-Yan
    Chen, Dongping
    Hu, Chaosu
    Yang, Kunyu
    Wen, Jiyu
    Li, Jingao
    Shi, Ying-Rui
    Jin, Feng
    Xu, Ruilian
    Pan, Jianji
    Qu, Shenhong
    Li, Ping
    Hu, Chunhong
    Liu, Yi-Chun
    Jiang, Yi
    He, Xia
    Wang, Hung-Ming
    Lim, Wan-Teck
    Liao, Wangjun
    He, Xiaohui
    Chen, Xiaozhong
    Liu, Zhigang
    Yuan, Xianglin
    Li, Qi
    Lin, Xiaoyan
    Jing, Shanghua
    Chen, Yanju
    Lu, Yin
    Hsieh, Ching-Yun
    Yang, Muh-Hwa
    Yen, Chia-Jui
    Samol, Jens
    Feng, Hui
    Yao, Sheng
    Keegan, Patricia
    Xu, Rui-Hua
    NATURE MEDICINE, 2022, 28 (01) : 214 - 214
  • [44] Preliminary results of the phase II ALTER-H003 trial: Anlotinib plus toripalimab as a first-line treatment for patients with unresectable hepatocellular carcinoma.
    Lin Haifeng
    Ma Jie
    Zhuo Manyun
    Zhang Chengsheng
    Luo Jingru
    Zhuang Xiaohong
    Zeng Zhiming
    Yang Lihua
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [45] Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
    Peng, Zhenwei
    Fan, Wenzhe
    Zhu, Bowen
    Wang, Guoying
    Sun, Junhui
    Xiao, Chengjiang
    Huang, Fuxi
    Tang, Rong
    Cheng, Yu
    Huang, Zhen
    Liang, Yuchuang
    Fan, Huishuang
    Qiao, Liangliang
    Li, Fuliang
    Zhuang, Wenquan
    Peng, Baogang
    Wang, Jiping
    Li, Jiaping
    Kuang, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (01) : 117 - +
  • [46] Phase II trial of hepatic arterial infusion chemotherapy using cisplatin and 5-fluorouracil in patients with advanced hepatocellular carcinoma
    Tanaka, M
    Ando, E
    Yutani, S
    Fukumori, K
    Kuromatsu, R
    Shimauchi, Y
    Nagamatsu, H
    Matsugaki, S
    Itano, S
    Ono, N
    Sakisaka, S
    Sata, M
    PROGRESS IN HEPATOCELLULAR CARCINOMA TREATMENT, 2000, : 49 - 55
  • [47] Lenvatinib combined with transarterial chemoembolization as first-line treatment of advanced hepatocellular carcinoma: A phase 3, multicenter, randomized controlled trial
    Peng, Zhenwei
    Fan, Wenzhe
    Zhu, Bowen
    Li, Jiaping
    Kuang, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [48] Updated results of the phase II ALTER-H003 trial: Anlotinib plus toripalimab as a first-line treatment for patients with unresectable hepatocellular carcinoma.
    Lin, Haifeng
    Ma, Jie
    Zhuo, Manyun
    Zhang, Chengsheng
    Luo, Jingru
    Zhuang, Xiaohong
    Zeng, Zhiming
    Yang, Lihua
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] A phase II trial of hepatic arterial infusion chemotherapy and bevacizumab in combination with toripalimab for advanced biliary tract cancers: Interim report
    Wang, X.
    Fu, S.
    Zheng, K.
    Cao, G.
    Xu, L.
    Yang, R.
    Zhu, X.
    Liu, P.
    Gao, S.
    Xu, H.
    Guo, J.
    Chen, H.
    Wang, K.
    Li, J.
    Zhou, J.
    Zhang, X.
    Hao, C.
    Xing, B.
    Shen, L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S568 - S568
  • [50] Efficacy of hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma
    Yang Hyun Baek
    Kyoung Tae Kim
    Sung Wook Lee
    Jin Sook Jeong
    Byeong Ho Park
    Kyung Jin Nam
    Jin Han Cho
    Young Hoon Kim
    Young Hoon Roh
    Hyung Sik Lee
    Young Min Choi
    Sang Young Han
    World Journal of Gastroenterology, 2012, (26) : 3426 - 3434
12345